GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill

Core Insights - GoodRx has announced the availability of the newly FDA-approved Wegovy® pill (oral semaglutide) at a cash price of $149 per month at over 70,000 pharmacies across the U.S. [1] - The platform will soon enable consumers to connect with licensed healthcare providers for weight management through GoodRx for Weight [1] Company Overview - GoodRx is recognized as the leading platform for medication savings in the United States [1] Product Details - Wegovy® is now available for consumers at a competitive cash price, enhancing accessibility to this medication [1] - The introduction of Wegovy® aligns with GoodRx's mission to provide affordable healthcare options [1]